Investigational Biomarkers in Patients with Chronic Renal Failure

Journal Title: Eastern Journal of Medical Sciences - Year 2018, Vol 3, Issue 4

Abstract

Background: Several studies showed that urinary concentration of neutrophil gelatinase-associated lipocalin (NGAL) increased in patients with chronic heart failure and mildly reduced glomerular filtration rate (GFR). Objective: To compare the NGAL levels between patients with high N-terminal pro-brain natriuretic peptide (NT-proBNP) levels and those with low NT-proBNP levels. Methods: In this case control study, we estimated the GFR, NT-proBNP, NGAL and fibroblast growth factor 23 (FGF- 23) levels in twenty peritoneal dialysis patients, along with twenty age- and sex-matched healthy controls. Therefore, in patients with NT-proBNP levels higher than 1000 pg/mL (hypervolemic patients) and in patients with NT-proBNP lower than 1000 pg/mL (normovolemic patients), serum NGAL and parameters of echocardiography were evaluated at the beginning of the study and again after three months. Results: In this study, patients’ serum NT-proBNP levels, NGAL and FGF23 were significantly higher than in the healthy control group (p <0.05). There were no significant differences between hypervolemic patients and normovolemic patients with regard to age, sex, body mass index, serum creatinine, parathyroid hormone, blood urea nitrogen (BUN), urine volume, GFR and left ventricular end-diastolic diameter, left atrial diameter or aortic root size measured by echocardiographic evaluation at the beginning and at the second measurement (p >0.05). Plasma NT-proBNP levels were markedly greater in hypervolemic patients (13323.3±11235.9 pg/mL) than those of normovolemic patients (456.1±266.7 pg/mL) (p <0.05). In hypervolemic patients, there was a significant decrease in NT-proBNP levels at the second measurement (from 13323.3±11235.9 pg/mL to 9667.3±9483.2 pg/mL) (p <0.05). However, no significant changes were detected in serum NGAL levels, FGF23 or GFR. In normovolemic patients, serum NT-proBNP, NGAL, FGF23 and GFR did not change (p >0.05). Conclusion: Serum NT-proBNP, NGAL and FGF23 levels are significantly higher in dialysis patients. This further indicates the need for a more comprehensive study of hypervolemia and the reduction of NGAL and residual renal function, which we often encounter in patients with renal insufficiency.

Authors and Affiliations

Derya Sahin, Hulya Taskapan

Keywords

Related Articles

Internalized Homophobia and Coming out Process in Adolescence: A Case Report

For homosexual individuals, on the basis of self-directed homophobic attitudes and difficulties experienced during the coming out process, their society’s heterosexist and homophobic attitudes are specifically considered...

Does Fear of Giving Birth Impact the Self-Efficacy Perceptions of a Pregnant Woman?

Background: The fear of death during delivery develops before pregnancy; it is called "tokophobia". Aim: To compare the self-efficacy perceptions of pregnant women based on the degree of their fear of giving birth and to...

PET-CT imaging of Carcinoma of the Oesophagus: The Kwa-Zulu Natal perspective

The introduction of computer software which enables assessment of various metabolic parameters has added value to the imaging, diagnosis and prognosis of oesophageal carcinoma (OC). Positron emission tomography/Computed...

Prediction of Low Factor V Levels in Patients with Herbal Medicine Related Acute Liver Injury

Background: Prior epidemiologic studies predicted a rapid rise in herbal medicine-related acute liver injury (HILI) and liver transplantation (LT) as trading of traditional herbal medicine drugs is expanded. HILI is the...

Download PDF file
  • EP ID EP527243
  • DOI -
  • Views 71
  • Downloads 0

How To Cite

Derya Sahin, Hulya Taskapan (2018). Investigational Biomarkers in Patients with Chronic Renal Failure. Eastern Journal of Medical Sciences, 3(4), 57-65. https://www.europub.co.uk/articles/-A-527243